Renal cell carcinoma (RCC) accounts for 85% of all primary renal cancers. The definitive
diagnosis of RCC relies exclusively on the subjective pathological interpretation of the …

BACKGROUND: New optical techniques of spectroscopy have shown promising results in
the evaluation of solid tumours. OBJECTIVE: To evaluate the potential of Raman …

Objective: To comprehensively analyze the relative effectiveness of Raman spectroscopy
(RS) in the diagnosis of suspected kidney cancer. Patients and methods: We performed a …

METHODS The tissues for analysis were from an IRB approved tissue bank. Three
specimens were selected for each subtype of RCC including clear cell, papillary, and …

The accuracy of renal mass biopsy to diagnose malignancy can be affected by multiple
factors. Here, we investigated the feasibility of Raman spectroscopy to distinguish malignant …

In this study, we propose to evaluate the potential of Raman spectroscopy (RS) to assess
renal tumours at surgery. Different classes of Raman renal spectra acquired during a clinical …

Renal mass biopsy is still controversial due to imperfect accuracy. Raman spectroscopy
(RS) demonstrated promise as an in vivo real‐time, nondestructive diagnostic tool in many …

Introduction Renal tumor biopsy requires adequate tissue sampling to aid in the
investigation of small renal masses. In some centers the contemporary nondiagnostic renal …

Raman molecular imaging was evaluated as a tool for differentiating between kidney tumors
which are sometimes confused using conventional histopathological methods. Renal …

High pathologic tumor-node-metastasis (pTNM) stage grade or Fuhrman grade indicates
poor oncological outcome in renal cell carcinoma (RCC). Early diagnosis and screening of …